0
ARTICLE |

USE OF MEPROBAMATE (MILTOWN) IN CONVULSIVE AND RELATED DISORDERS

Meyer A. Perlstein, M.D.
JAMA. 1956;161(11):1040-1044. doi:10.1001/jama.1956.02970110006003.
Text Size: A A A
Published online

• Meprobamate, which gives muscular relaxation without significant effects on circulation and respiration, was administered by mouth to 130 patients with various nervous disorders characterized by seizures, hyperactivity, or tension form of cerebral palsy. The most convincing relief of symptoms was found in 18 patients with idiopathic petit mal, where 15 were helped significantly and none were made worse. The drug was much less effective in idiopathic grand mal; in fact, 3 out of 14 patients with grand mal were made worse. The drug was also of some value in decreasing the tension of patients with athetosis and with some behavior disturbances. The dosage was 100 to 800 mg., generally given two to four times a day, and this was increased until either clinical benefit or drowsiness resulted. The time of effective action was about four hours. The dosage used in this study did not cause any toxic side-effects.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();